相关实验视频
Updated: Jan 13, 2026
10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
36.4K
通过ERK2的EIF4BSer93酸化促进了上皮细胞-介质细胞的过渡,从而推动结直肠癌的转移
Siqi Wen1,2, Min Lin1, Man Zhang1
1Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Cell death & disease
|January 6, 2026
概括
结肠直肠癌 (CRC) 的进展是由eIF4B Ser93酸化驱动的,这种酸化增强了转移. 向这种酸化为CRC治疗提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
- 皮质转移到介质细胞转移 (EMT) 是CRC转移和预后不佳的关键驱动因素.
- 异常的蛋白质酸化在CRC进展中起着至关重要的作用.
研究的目的:
- 研究蛋白质酸化在结直肠癌进展中的作用.
- 在CRC中识别与EMT相关的关键酸化事件.
- 探索eIF4B Ser93酸化作为CRC中潜在的治疗标.
主要方法:
- 基于标签的双重质量标签 (TMT) 蛋白质组分析,以确定CRC中改变的蛋白质酸化.
- 在CRC组织和细胞系中使用特定抗体验证eIF4B Ser93酸化.
- 在体外和体内实验中评估eIF4B Ser93酸化对CRC进展和转移的影响.
- 机制研究以阐明ERK2在eIF4B酸化中的作用及其下游影响.
主要成果:
- 在CRC中发现了蛋白质酸化的显著变化,主要与EMT有关.
- 在CRC中,Ser93的eIF4B酸化显著增加,促进瘤生长和转移.
- eIF4B Ser93的酸化降低了其降解,并增强了间酶体标记物的转化.
- ERK2在Ser93处直接化eIF4B,其抑制对抗癌药物疗效至关重要.
结论:
- 由ERK2驱动的eIF4B Ser93酸化通过激活EMT促进CRC生长和转移.
- 向eIF4B Ser93酸化是一种针对结直肠癌的新治疗策略.
- 这些发现为人类CRC的临床干预提供了有希望的途径.
相关概念视频
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:07MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
02:30Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
01:35Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K